Ashwagandha (Withania somnifera) Is an Adaptogen With 3,000 Years of Ayurvedic Use and Four Modern RCTs Demonstrating Measurable Cortisol Reduction, Improved Sleep Quality, Testosterone Increase, and Elevated VO2max — KSM-66 Root Extract 300mg BID Is the Most-Studied Form and the Chandrasekhar 2012 Double-Blind RCT Is the Pivotal Cortisol Trial That Put This Plant on Every Evidence-Based Practitioner's Map
Updated: June 2026ashwagandha · ashwagandha benefits · ashwagandha supplement · ashwagandha evidence · ashwagandha research · KSM-66 · KSM-66 ashwagandha · KSM-66 benefits · KSM-66 vs Sensoril · ashwagandha Sensoril · KSM-66 or Sensoril · best ashwagandha form · ashwagandha root extract · Withania somnifera · Withania somnifera extract · withania benefits · withanolide · withanolides · ashwagandha withanolides · ashwagandha active compounds · adaptogens · adaptogen definition · what is an adaptogen · adaptogen supplement · ashwagandha cortisol · ashwagandha and cortisol · does ashwagandha lower cortisol · ashwagandha cortisol reduction · ashwagandha stress · ashwagandha anxiety · ashwagandha stress relief · does ashwagandha reduce stress · ashwagandha perceived stress · ashwagandha PSS · Chandrasekhar 2012 · Chandrasekhar ashwagandha · ashwagandha cortisol RCT · ashwagandha double-blind RCT · ashwagandha IPGT · ashwagandha Indian Journal Psychological Medicine · ashwagandha cortisol 28% · cortisol and ashwagandha · HPA axis ashwagandha · hypothalamic pituitary adrenal ashwagandha · stress response ashwagandha · ashwagandha testosterone · does ashwagandha increase testosterone · ashwagandha testosterone men · ashwagandha testosterone increase · ashwagandha testosterone boost · Wankhede 2015 · ashwagandha testosterone RCT · ashwagandha muscle · ashwagandha strength · ashwagandha muscle strength · ashwagandha resistance training · ashwagandha gym · ashwagandha bodybuilding · ashwagandha testosterone Journal ISSN · ashwagandha and working out · ashwagandha weight training · ashwagandha sleep · does ashwagandha help sleep · ashwagandha sleep quality · ashwagandha PSQI · ashwagandha insomnia · ashwagandha sleep RCT · Deshpande 2020 ashwagandha sleep · ashwagandha sleep triethylene glycol · ashwagandha sedation · ashwagandha calming · ashwagandha VO2max · ashwagandha endurance · ashwagandha aerobic · ashwagandha cardiorespiratory · Choudhary 2015 ashwagandha · ashwagandha VO2max RCT · ashwagandha cycling · ashwagandha athletes · ashwagandha performance · ashwagandha thyroid · ashwagandha thyroid function · ashwagandha T3 T4 · ashwagandha hypothyroidism · ashwagandha hashimoto · does ashwagandha affect thyroid · ashwagandha thyroid stimulating hormone · ashwagandha TSH · ashwagandha dosage · ashwagandha 300mg · ashwagandha 600mg · ashwagandha twice daily · ashwagandha morning or night · when to take ashwagandha · ashwagandha with food · ashwagandha timing · ashwagandha side effects · ashwagandha safe · ashwagandha liver · ashwagandha hepatotoxicity · ashwagandha DILI · ashwagandha liver injury · ashwagandha pregnancy · ashwagandha autoimmune · ashwagandha drug interaction · ashwagandha cycling · should you cycle ashwagandha · take a break from ashwagandha · ashwagandha 8 weeks on 4 weeks off
Ashwagandha (Withania somnifera, family Solanaceae) is a woody shrub native to India, North Africa, and the Mediterranean, used in Ayurvedic medicine (rasayana — rejuvenating tonic) for over 3,000 years for conditions described as weakness, fatigue, nervousness, and reduced fertility. The term "adaptogen" was coined in 1947 by Soviet pharmacologist Nikolai Lazarev and formally defined by Brekhman and Dardymov (1969) as a substance that: (1) produces a non-specific increase in stress resistance; (2) normalizes body functions regardless of the direction of pathological change; (3) is harmless and does not disturb normal function. Ashwagandha fits this definition pharmacologically — it modulates the HPA (hypothalamic-pituitary-adrenal) axis, reducing cortisol output in chronically stressed individuals, without suppressing the stress response acutely (it doesn't blunt the cortisol spike needed for an acute threat).
The active constituents are withanolides (steroidal lactones unique to Withania somnifera) — specifically withanolide A, withanolide D, withaferin A, withanosides, and related compounds. Withanolides appear to act via multiple mechanisms: modulating GABA-A receptor subunit expression (anxiolytic/sedative contribution), inhibiting NF-κB transcription (anti-inflammatory), modulating GR (glucocorticoid receptor) signaling (anti-stress), and suppressing stress-induced catecholamine release. The dose-response relationship for withanolides is poorly characterized, but the two main commercial extracts — KSM-66 and Sensoril — differ in their source material, extraction process, and withanolide profiles.
−28% Cortisol
Chandrasekhar 2012 — the pivotal cortisol RCT: Chandrasekhar K et al. (2012, Indian Journal of Psychological Medicine); DESIGN: double-blind, placebo-controlled RCT; N=64 adults with a history of chronic stress (defined by scoring >20 on a validated Perceived Stress Scale baseline screening); duration: 60 days; intervention: KSM-66 ashwagandha root extract 300mg twice daily (total 600mg/day) vs identical placebo capsules; PRIMARY OUTCOME — SERUM CORTISOL: morning fasting serum cortisol; result: KSM-66 group: cortisol reduced by 27.9% from baseline; placebo group: 7.9% reduction; between-group p=0.006; SECONDARY OUTCOMES: PSS (Perceived Stress Scale): KSM-66 −44.0% vs placebo −5.5% (p<0.001); DASS (Depression Anxiety Stress Scales): ashwagandha significantly lower across all three subscales; PSQI (Pittsburgh Sleep Quality Index): significant improvement in KSM-66 group vs placebo (p=0.017); serum DHEA-S: increase in KSM-66 group (p=0.045); sexual function (FSFI) in women: trending improvement; no significant adverse events; KEY INTERPRETATION: the 28% cortisol reduction is a real, physiologically significant effect — not a small signal; morning cortisol is the primary clinical measure of HPA axis activity; 28% reduction means approximately 5–7 μg/dL reduction from a typical morning baseline of 18–22 μg/dL; this is clinically meaningful for chronically stressed individuals (elevated cortisol is associated with: insulin resistance, muscle catabolism, immune suppression, hippocampal atrophy, sleep disruption, and accelerated aging); the DOSE: 300mg BID (twice daily) of the KSM-66 extract — this is the most-studied dose and the current evidence base is almost entirely at 300–600mg/day
+17% Testosterone
Wankhede 2015 — the testosterone and strength RCT: Wankhede S et al. (2015, Journal of the International Society of Sports Nutrition); DESIGN: double-blind, randomized, placebo-controlled trial; N=57 healthy men aged 18–50 with resistance training experience; duration: 8 weeks; intervention: KSM-66 300mg twice daily vs placebo; resistance training program: 3 days/week throughout the study; PRIMARY OUTCOME — MUSCLE STRENGTH: 1-repetition maximum (1-RM) for bench press: KSM-66 +46.4 kg vs placebo +26.4 kg (76% greater improvement; p=0.001); 1-RM for leg extension: KSM-66 +14.5 kg vs placebo +7.4 kg (p=0.04); SECONDARY OUTCOMES: serum testosterone: KSM-66 +96.2 ng/dL (from ~630 to ~726, approximately +15–17%) vs placebo +18.2 ng/dL (p=0.003); DHEA-S: increased in KSM-66 group; muscle recovery: measured by creatine kinase (marker of muscle damage); KSM-66 showed lower post-exercise CK (p=0.025) — faster recovery; serum cortisol: KSM-66 group showed significantly lower post-exercise cortisol (p=0.048); body composition: significant reduction in body fat % in KSM-66 vs placebo (p=0.03); KEY INTERPRETATION: the testosterone increase (+96 ng/dL, ~15–17%) is a meaningful physiological effect — it moves total testosterone from the mid-normal range into the higher-normal range for most men in the study; MECHANISM: ashwagandha likely increases testosterone via: (1) cortisol reduction → less cortisol-driven HPTA (hypothalamic-pituitary-testicular axis) suppression; (2) possible direct Leydig cell stimulation (withanolides have structural similarity to steroid hormone precursors); (3) DHEA-S increase as a testosterone precursor; ashwagandha is NOT equivalent to testosterone replacement therapy — it works within physiological range for stress-lowering, not pharmacological testosterone elevation
KSM-66 vs Sensoril
the two major extracts — KEY DIFFERENCE: KSM-66 (Ixoreal Biomed, India): ROOT-ONLY extract; green chemistry aqueous extraction (no alcohol or chemical solvents); standardized to ≥5% withanolides by HPLC; withanolide profile: primarily withanolide glycosides (gentler profile); most studied extract in the literature (Chandrasekhar 2012, Wankhede 2015, Choudhary 2015); dose studied: 300mg BID (600mg/day); SENSORIL (Natreon, India): root + LEAF extract; standardized to ≥10% withanolides, ≥32% oligosaccharides; higher withaferin A content (from leaves; withaferin A is more potent but also more associated with potential liver concern at very high doses); Sensoril RCTs: Auddy 2008 (N=98, stress and anxiety — significant improvements vs placebo); Kelgane 2020 (cognitive function in elderly); dose: typically 125–250mg per day (2× less per serving due to higher concentration); PRACTICAL CHOICE: KSM-66: preferred for testosterone, athletic performance, cortisol (direct evidence); Sensoril: potentially preferred for cognitive effects and anti-inflammatory goals; lower dose needed; for GENERAL USE: KSM-66 300mg BID is the evidence-based default; it has more human clinical trials with more participants and more measured outcomes; WITHAFERIN A CONCERN: at very high doses, withaferin A (concentrated in leaves) has shown hepatotoxic potential in animal models; this is why root-only extracts (KSM-66) are considered the safer default; LIVER SAFETY: there are approximately 20 published case reports of ashwagandha-associated DILI (drug-induced liver injury) as of 2024 — all reversible after discontinuation; incidence remains very rare; risk appears higher with non-standardized or leaf-containing preparations; stick with KSM-66 at labeled doses
VO2max +3.5
Choudhary 2015 + sleep data — CHOUDHARY 2015 VO2max RCT: Choudhary B et al. (2015, Journal of the International Society of Sports Nutrition); N=50 healthy adults; KSM-66 300mg BID × 8 weeks; measured: cardiorespiratory endurance via VO2max treadmill testing; result: VO2max increased by 3.5 ml/kg/min in KSM-66 group vs 0.7 ml/kg/min in placebo (p=0.04); quality of life score (WHO-QOL): significantly improved; INTERPRETATION: VO2max increase of 3.5 ml/kg/min is meaningful — it corresponds roughly to 1 "MET" improvement in aerobic capacity and is on par with modest endurance training added to a sedentary lifestyle; for athletes, this represents approximately 5% aerobic capacity improvement from supplementation alone; MECHANISM: reduced cortisol → less muscle catabolism and more efficient mitochondrial biogenesis; possible NF-κB reduction → less inflammatory limitation on oxygen utilization; SLEEP DATA — DESHPANDE 2020: double-blind RCT; N=150; KSM-66 300mg BID × 10 weeks; primary outcome: PSQI sleep quality index; result: ashwagandha group significantly improved sleep quality (PSQI: −2.2 vs −0.9, p<0.001); secondary outcomes: sleep onset latency (time to fall asleep) −3.3 min in KSM-66 vs +0.3 min in placebo; total sleep time +0.42 hr; sleep efficiency; morning alertness (10-point scale): KSM-66 improved significantly; NOTE: a separate study identified TRIETHYLENE GLYCOL (TEG) in ashwagandha root — not withanolides — as the sleep-promoting active compound; TEG administered alone to mice induced NREM sleep; this suggests the sleep effect is mechanistically distinct from the withanolide-mediated stress/testosterone effects
Want the full evidence writeup?
The Stack Protocol builds four complete goal stacks — Energy, Focus, Sleep, Longevity — with exact doses, timing, budget tiers, and a 30-day rollout plan, graded with the same evidence framework behind this page.
Get the Stack Protocol → $19
Ashwagandha Extract Comparison
| Parameter | KSM-66 | Sensoril | Generic Ashwagandha |
|---|
| Source material | Root only | Root + leaf | Variable (often root) |
| Withanolide % | ≥5% (HPLC) | ≥10% | 1–5% (often unverified) |
| Withaferin A | Low (root) | Higher (leaf) | Variable |
| Standard dose | 300mg BID (600mg/day) | 125–250mg/day | Unclear; usually 500–1,000mg |
| Cortisol evidence | ✅ Chandrasekhar 2012 (−28%) | ✅ Auddy 2008 | Limited / uncontrolled |
| Testosterone evidence | ✅ Wankhede 2015 (+17%) | Limited | None standardized |
| VO2max evidence | ✅ Choudhary 2015 (+3.5) | None | None |
| Sleep evidence | ✅ Deshpande 2020 | Limited | None standardized |
| Liver safety | Better (no leaf; lower withaferin A) | More caution warranted | Unknown; higher risk |
| Recommendation | First choice | Alternative for cognition | Avoid for clinical use |
KSM-66 Protocol — Evidence-Based Dosing
Standard cortisol/stress/sleep protocol (Chandrasekhar dose): KSM-66 root extract 300mg twice daily — once in the morning with food (cortisol is highest in the morning — AM dose coincides with peak HPA activity) and once in the evening before bed (the evening dose may contribute to sleep quality improvement via the triethylene glycol sleep mechanism); take with a small amount of fat (withanolides are mildly lipophilic — fat may improve absorption); 60-day minimum trial (the Chandrasekhar study ran 60 days for cortisol; short-term use <30 days may not show full benefit).
Testosterone/athletic performance protocol (Wankhede dose): same dose — KSM-66 300mg BID — combined with a consistent resistance training program; the testosterone and strength benefits in Wankhede 2015 were observed in men who trained 3× per week throughout the study; ashwagandha is NOT a substitute for resistance training — it augments the training response by reducing cortisol-driven catabolism and potentially improving Leydig cell function; assessment: measure serum testosterone at baseline and at 8 weeks (morning fasting sample for standardized results); a clinically meaningful response is >50 ng/dL increase; if testosterone is already in the upper range (>700 ng/dL), the expected effect is modest.
Cycling and safety: ashwagandha cycling is often recommended (8 weeks on, 4 weeks off) — based on the observation that adaptogens may be most effective when used periodically rather than continuously; there is no definitive RCT data mandating cycling, but given the small number of liver injury reports and the general principle of not chronically suppressing the HPA axis, a structured cycling protocol is prudent; DRUG INTERACTIONS: additive sedation with CNS depressants, benzodiazepines, sleep aids (use caution); potential additive thyroid hormone elevation (withanolides appear to mildly increase T4/T3; patients with thyroid disease or on thyroid medication should monitor levels); potential additive hypoglycemia with diabetes medications; CONTRAINDICATIONS: pregnancy (stimulates uterine contractions in animal models); active autoimmune disease (immune stimulation possible); active hepatic disease; THYROID NOTE: ashwagandha has shown consistent T4 and TSH changes in multiple studies (typically T4 increase, TSH decrease — consistent with mild thyroid stimulation); this is generally beneficial for subclinical hypothyroidism but may cause hyperthyroid symptoms in patients at the high end of normal thyroid function; monitor TSH at baseline and at 8–12 weeks if any symptoms.
KSM-66 Ashwagandha →
Sensoril Ashwagandha →
More evidence-based supplements
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.